Literature DB >> 8599899

A case of Rathke's cleft cyst presenting with diabetes insipidus.

Y Erşahin1, N Ozdamar, E Demirtaş, S Mutluer.   

Abstract

Rathke's cleft cysts (RCCs) are considered to arise from the remnants of Rathke's pouch, an invagination of the stomodeum. They are classically described as benign epithelium lined intrasellar cysts containing mucoid material, and also found in 2-33% of routine autopsy series. The most common presenting symptoms are visual impairment, hypothalamic dysfunction, hypopituitarism and headache. Diabetes insipidus has been described in patients with RCC. Very few cases presented with only diabetes insipidus in adults. To our knowledge, our patient is the first case of RCC presenting with only diabetes insipidus in childhood. A 9-year-old girl presented with diabetes insipidus. The physical, neurological and endocrinological examinations were normal, except for diabetes insipidus. Magnetic resonance imaging scan revealed a hyperintense lesion with supra sellar extension in the posterior pituitary both on T1 and T2 weighted images. Subtotal excision of RCC was performed via transsphenoidal surgery. However, diabetes insipidus persisted after the surgery.

Entities:  

Mesh:

Year:  1995        PMID: 8599899     DOI: 10.1016/0303-8467(95)00050-t

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Symptomatic Rathke's cleft cysts: a radiological, surgical and pathological review.

Authors:  Domenico Billeci; Elisabetta Marton; Massimo Tripodi; Enrico Orvieto; Pierluigi Longatti
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 2.  Neuroimaging of central diabetes insipidus-when, how and findings.

Authors:  N C Adams; T P Farrell; A O'Shea; A O'Hare; J Thornton; S Power; P Brennan; S Looby
Journal:  Neuroradiology       Date:  2018-08-10       Impact factor: 2.804

3.  A case of Rathke's Cleft Cyst inflammation presenting with diabetes insipidus.

Authors:  J W Yoon; S K Jo; D R Cha; W Y Cho; H K Kim
Journal:  Korean J Intern Med       Date:  2001-06       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.